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Abstract 
Understanding the cell response to oxidative stress in disease is an important but difficult task. Here, 
we demonstrate the feasibility of using a nanomotion sensor to study the cellular metabolic landscape. 
The sensor permits the non-invasive real-time detection at the single-cell level and offers high 
sensitivity and time resolution.  We optimised the technique to study the effects of frataxin 
overexpression in a cellular model of Friedreich’s ataxia, a neurodegenerative disease caused by 
partial silencing of the FXN gene. Previous studies had demonstrated that FXN overexpression are as 
toxic as silencing thus indicating the importance of a tight regulation of the frataxin levels. We probed 
the effects of frataxin overexpression in the presence of oxidative stress insults and measured the 
metabolic response by the nanosensor. We show that the nanosensor provides new detailed 
information on the metabolic state of the cell as a function of time that agrees with and complements 
data obtained by more traditional techniques. We propose that the nanosensor can be used in the 
future as a new and powerful tool to study directly how drugs modulate the effects of oxidative stress 
on Friedreich’s ataxia patients and, more in general, on other neurodegenerative processes. 
  
Introduction 
Understanding the primary causes of a disease is central to design ways to prevent pathology. This is 
not a problem in infective diseases in which the primary causative agent, when known, is clear and 
determinant. More difficult is to deal with neurodegenerative diseases of which we have still only a 
partial and confusing understanding. We for instance ignore when the different events that are often 
associated with neurodegeneration such as inflammation, oxidative stress, metabolic changes, occur. 
Currently, the only way to follow these processes is to take reads of different biomarkers from patients 
or animal model samples at specific quantised time points and use them as objectively measurable 
parameters that reflect the pathogenic processes or the response to therapeutic pharmacologic 
intervention. This approach is appropriate in many cases but can miss completely the early events of 
disease development or confuse primary causes with secondary effects [1]. Conventional bulk 
biological assays are also limited by the intrinsic cellular heterogeneity in gene, protein and 
metabolite expression and investigate the cellular status only indirectly. In search for new 
methodologies able to assist both basic studies of molecular mechanisms, drug discovery and 
diagnosis, we implemented the use of a novel bio-nanosensor, named nanomotion sensor, a device 
able to perform real-time, single-cell correlated measurements of different cellular nanoscale 
biomotions [2]. This innovative methodology combines conventional bio-investigation techniques 
and nanomechanical oscillators, typically an AFM cantilever [3], to obtain with modest costs a small 
and manageable device that can transduce in measurable fluctuations the nanoscale metabolically-
related cellular movements or vibration [4]. These signals can be used to study the cellular response 
to physical or chemical external stimuli. The response reflects in turns the metabolic activities of the 
cell and gives us a quantitative measure of the viability of the cellular specimen [5]. The nanosensor 
can be used to study cellular reactions and cytotoxicity an order of magnitude faster and using 100-
fold smaller volume of reagents when compared to conventional analyses: this methodology allows 
monitoring the response to external stimuli in the order of hours, i.e. way before what can be done by 
the conventional high-throughput bulk assays, and provides a platform of unparalleled sensitivity and 
time resolution to monitor in continuo different biological systems, such as bacteria, yeast and 
mammalian cells [6, 7]. The approach has already been used to investigate a large variety of molecular 
[8], cellular [9], microbiological [10, 11] and clinical problems [12]. We have for instance used the 
nanosensor to study single neuroblastoma cells exposed to extracellular monomeric and amyloid α-
synuclein, the protein involved in Parkinson disease [9, 13]. By combining the nanosensor with 
fluorescence microscopy, we demonstrated that α-synuclein aggregates lead to cooperative cytotoxic 
effects and aggregate-induced loss of cellular membrane integrity. We also employed the nanomotion 
sensor to characterize the status of Calmette-Guérin Mycobacterium bacilli and non-tuberculous 
Mycobacteria treated with different antibiotics to study the effects and efficacy of the drugs [11]. We 
convincingly showed how the high-speed and high-sensitivity of the nanosensor provide a rapid and 
reliable method to study the response of the bacillus to drugs. 
    Here, we implemented the nanosensor to study human cells modified to switch on/off the 
FXN gene implicated in Friedreich's ataxia (FRDA) [14]. This is an autosomal recessive disease 
caused by trinucleotide repeats expansion which leads to partial silencing of the frataxin gene. FRDA 
patients and frataxin animal knock-outs have Fe3+ accumulation and oxidative stress which become 
more severe with aging [15-17]. It has long been debated whether oxidative stress is the cause of 
FRDA or the consequence after a long series of primary events [17]. The FRDA disease is thus an 
optimal case study which could strongly benefit from the nanosensor technology to explore in detail 
the early stages of disease and follow the metabolic status of FRDA cells. Using the CRISPR/Cas9 
technology, we developed in the past a mammalian cell line (HEK-cFXN) which can produce 
different frataxin levels by switching off partially or completely the FXN gene [18]. This system, 
which was the first after the exploratory study by Ristow and coworkers to use mammalian cells [19], 
allowed us to introduce a temporal dimension to the study the early events of FRDA. In a previous 
study that relied on traditional techniques such as fluorescence analysis and enzymatic assays, we 
showed that overexpression of the frataxin gene affects the cellular metabolism and leads to a 
significant increase of oxidative stress and labile iron pool levels. These cellular effects are similar to 
those observed when the gene is partially silenced, as it is in FRDA patients [20]. 
 We demonstrated that the nanosensor is a powerful and flexible technique able to provide 
important information on the metabolic changes caused by frataxin deficiency which is in agreement 
with and complement the conclusions obtained by conventional techniques. We showed that the cell 
has a clear response to frataxin overexpression under oxidative stress conditions that is characterized 
by multiple steps of metabolic activity. We validated our conclusions with fluorescence 
measurements that provided a complementary but coherent perspective. The information obtained by 
the nanosensor, coupled with more traditional techniques, can thus help us to study the metabolic 
landscape of the cellular response. We envisage that this technique will turn in the future into an 
important tool able to assist FRDA studies and eventually be exploited to inform on the effects of 
new therapeutics directly on patients’ cells. 
 
Materials and methods 
Cellular model 
The cellular model, HEK-cFXN, used in this study is a derivative HEK293 cell line characterised by 
a CRISPR-induced biallelic knockout of the endogenous FXN gene and the presence of an exogenous, 
inducible cDNA FXN cassette (cFXN). The cFXN gene is under the control of a tetracycline regulated 
promoter (CMV-TetO2) that allows switching off/on the cFXN gene [18]. This system can result in 
induction of increasing levels of the protein as a function of the tetracycline concentration. The HEK-
cFXN model has been previously used to study the effects of frataxin overexpression: cells cultured 
in the presence of 10 or 100 ng/ml tetracycline have levels of frataxin expression substantially 
increased respect to endogenous frataxin levels of wildtype HEK293 cells (13- and 17-fold increase, 
respectively). In both cases, the frataxin levels progressively decrease upon removal of tetracycline 
from the culture medium, reaching physiological levels after an 8-day period [20]. In the present 
study, we used HEK-cFXN cells grown in 10 (10-tet-HEK-cFXN) or 100 (100-tet-HEK-cFXN) ng/ml 
tetracycline as models for mild (10 ng/ml) and strong (100 ng/ml) frataxin overexpression. Cells at 
the 8-day period (8-day-HEK-cFXN) were considered as internal control cells for each of the 
overexpression levels since they produce basal frataxin levels of HEK cells. For each independent 
experiment the basal level was assumed the average response observed in the period before inducing 
an oxidative stress response.  
 
Cell culture 
Cell culture and reagents were acquired from ThermoFisher Scientific (Waltham, MA, USA). HEK-
cFXN cells were cultured in Dulbecco modified Eagle medium, supplemented with 10% tetracycline-
free fetal bovine serum (FBS; Clontech, Takara), 10 mM sodium pyruvate, 2 mM L-glutamine, 2% 
(v/v) non-essential amino acids (NEAAs), 100 μg/ml hygromycin B and 15 μg/ml blasticidin. Cells 
were kept in an incubator (Binder CB 150) at 37°C in humidified air enriched with 5% CO2.  
During the experiments, the culture medium was supplemented with either 10 or 100 ng/ml of 
tetracycline (Sigma-Aldrich, St. Louis, Missouri, USA) to obtain respectively mild and strong 
frataxin overexpression. Oxidative stress conditions were triggered by initially culturing cells 
overnight in the presence of 50 M ferric ammonium citrate (mild iron overload) followed by 30 min 
of 300 µM H2O2. 
 
Nanomotion assays 
We employed a Nanosurf FlexAFM 5 microscope to monitor the metabolically-related cellular 
fluctuations. The microscope was mounted on an Olympus IX50 inverted optical microscope 
(Olympus Inc., Tokyo, Japan) and connected to a National Instruments card for direct collection of 
the nanomotion signal. The AFM device was equipped with commercial cantilevers (Bruker DNP-
10, nominal spring constant 0.12 N/m) modified through chemical functionalization to ensure cell 
attachment to the sensor: the tips were exposed for 15 minutes to poly-D-lysine (20 µg/ml, Sigma-
Aldrich), followed by rinsing, air drying and immediate use. This functionalization protocol has been 
demonstrated most suitable for cellular attachment [21, 22]. The AFM device was inserted in the 
incubator to ensure that the cells under investigation would be kept under controlled temperature and 
CO2 conditions. We then used the AFM motors to move the functionalized sensor in the near 
proximity of a cell and applied on it a small pressure (5 nN). This procedure ensured attachment of 
the cell on the sensor, which was then retracted and used for the nanomotion experiment. We 
exploited conventional optical microscopy to determine the number and position of the attached cells 
on the cantilever sensor. In a typical nanomotion experiment, we collected continuously the 
oscillations of the sensor produced by the metabolic activity of the attached cells in several 
independent 30-minute periods over approximately 1-2 hours with an acquisition rate of 20 kHz. We 
first measured the cells in the presence of standard culture medium. We then added the oxidising 
agent (at a final concentration of 300 µM H2O2) to evaluate cell response over time,           over more 
than 40 minutes. We coupled the nanosensor measurements with optical images collected by the 
inverted microscope using a 40x objective. 
 
Data analysis 
The recorded fluctuations appeared as coloured noise patterns. We analysed the data by calculating 
the variance of the vibrations over time using a custom LabView software that performed the analysis 
in several steps. At first, the data were split in 30 second sets and a simple linear fit was applied to 
each set. Next, the variance within each set was calculated and separated according to whether the 
data were collected before and after the addition of the oxidising agent. We averaged the data points 
before the addition of the H2O2 and tagged the resulting value as 100% to evaluate the effect of the 
stimulus and allow comparison between the different experiments. The data after exposure to the 
oxidising agent were then averaged in groups representing data collected within 3-5 minutes to 
reconstruct the variance variation vs. time. All experiments were performed at least in triplicates using 
independently prepared cells and over different time-periods. The graphs presented are the average 
of minimally three experiments performed under the same conditions. 
 
MitoSOX Red assays 
Cell samples were incubated for 20 min at 37ºC with MitoSOX Red (Thermo Fisher Scientific, 
Waltham, MA, USA) at a concentration of 1.25 M. Measurements were carried out on 104 cells per 
sample by flow cytometry (BD Fortessa, excitation/emission at 488 nm and 710 nm, respectively) 
and the results are expressed as percentages of fluorescent cells on the whole population. Results are 
expressed as means of three to five independent samples for each condition. Statistical significance 
was tested using one-way ANOVA and Dunnett post hoc test (**P ≤0.0045; **** P ≤0.0001).  
 
Results 
Measurement of the cellular motion at the nanoscale 
The nanosensor consists of a cantilever on which cells are attached, following protocols developed 
previously [9] (Figure 1). The data are recorded as the amount of cellular motions as a function of 
time. We proved in the past that these movements correlate directly with the increasing and 
decreasing of the metabolic activity of the cell [4, 5]. Deviations from the baselines indicate cell 
viability and their intensities will indicate how much the cells treated by specific environmental 
insults differ from the controls in terms of metabolic behaviour. 
We first performed control experiments to establish the feasibility of the technique and define the 
default oscillations of the cellular response to the geometry of the setup and the functionalization of 
the sensor. We incubated 10-tet-HEK-cFXN and 100-tet-HEK-cFXN cells on the cantilever in the 
analysis chamber at 37°C. These assays showed how the cells survived on the sensor for more than 
one hour with little variations, both in morphology and nanomotion response (Figure 2). 
 
The effects of oxidative stress on HEK-cFXN cells 
Next, we monitored the cells when exposed to oxidative stress conditions. To evaluate the role of 
ferric ammonium citrate that mimics the condition of iron overload observed in FRDA patients, we 
performed nanomotion response experiments by comparing cells incubated in the presence of this 
sensitizing agent adding peroxide. The cells were all cultured overnight in the presence of ferric 
ammonium citrate (50 M). A cell sample was then collected by the cantilever and the measurement 
started. After a first stabilizing period of 1 h in growth medium, which set the average level of 
fluctuations for the specific condition, we introduced in the analysis chamber H2O2 to achieve a final 
concentration of 300 M. Depending on the levels of frataxin expression, the cells had strikingly 
different responses (Figure 3). Ten minutes after exposure to oxidative stress, the control cells 8-day-
HEK-cFXN showed a sharp reduction of the nanoscale movements (0.4%) which lasted less than 10 
minutes and rapidly returned to the basal levels (i.e. the levels observed after a stabilizing period of 
1 h) (Figure 3A). This is indicative that HEK-cFXN cells with endogenous frataxin levels are able to 
recover from oxidative stress rapidly and maintain a normal metabolic activity also in the presence 
of oxidative agents.  
The cells with frataxin mild overexpression (10-tet-HEK-cFXN cells) had a more complex 
response (Figure 3B). The response to H2O2 in this case was faster and more accentuated since the 
movements more rapidly (after 5 minutes) dropped by 0.6 units the signal observed before the 
peroxide insult. The response took almost 20 minutes to recover partially before entering in a second 
shallower minimum (a 0.35 units drop). Finally, the cells recovered rapidly (after less than 10 
minutes), stabilizing the signal to values comparable to the basal level. 
The cells with strong frataxin overexpression (100-tet-HEK-cFXN cells) also showed a 
nanomotion pattern with two minima. The data showed a sharp decrease of cellular movement with 
a minimum (a 0.7 units drop ca. 3 minutes after peroxide addition), which lasted 10 minutes (Figure 
3C). This behaviour was followed by a second shallower and wider minimum (0.2 units drop at 14 
minutes after the insult) and third one almost as deep as the first (0.50 units drop) 36 minutes after 
peroxide addition. In this case the cell response did not recover after 40 minutes indicating a more 
complex response pattern of these cells to oxidative agents, which was not completed at the end of 
the recording time. 
Notably, all response patterns were not associated to morphological indications of cell 
suffering or cell death as shown by optical images (Figure 4 for 8-day-HEK-cFXN, 10-tet-HEK-
cFXN and 100-tet-HEK-cFXN respectively).  
 
Effect of peroxide in the absence of iron overload 
We then controlled the effects of the peroxide without preincubation in ferric ammonium citrate. The 
10-tet-HEK-cFXN cells had a response similar to that of the 10-tet-HEK-cFXN cells incubated with 
ferric ammonium citrate evidencing two minima (Figure 5A). As for 8-day-HEK-cFXN, 5 minutes 
were needed to see a response to H2O2, but in this case the reduction of the movement was less intense 
and lasted longer (more than 20 minutes). Following the first minimum, the cell response had a second 
minimum of shorter length (15 minutes approximately). It is worth highlighting how the two minima 
were shallower, suggesting that the cell response was not as strong as for the exposure to ferric 
ammonium citrate but more diffuse. 
The 100-tet-HEK-cFXN cells also showed a two-minimum nanomotion pattern (Figure 5B). 
The first minimum was less intense (a 0.2 units drop after ca. 8 minutes) as compared to those 
measured in the presence of ferric ammonium citrate and lasted ca. 15 minutes. As for the 10-tet-
HEK-cFXN cells, the response was slower and required almost ten minutes to reach a minimum. The 
second minimum was deeper (a 0.5 units drop after ca. 35 minutes) than the first. 
Overall, these experiments demonstrated that cells which were not sensitized with ferric 
ammonium citrate appeared to respond less intensely and slower to oxidative stress. Also in these 
experiments, we did not observe large-scale morphological changes indicating cell suffering or cell 
death (Figure 5C).  
 Detection of oxidative stress by fluorescence 
We have previously described the effects of oxidative stress on HEK-cFXN cells [20]. Overall, our 
previous results are in excellent agreement with the nanosensor experiments. To further validate the 
nanomotion technology, we adopted the widely used MitoSOX Red, a fluorescent dye used for the 
detection of ROS formation specifically in mitochondria [23]. Detection of ROS formation via 
MitoSOX Red fluorescence was performed not only on samples exposed to ferric ammonium citrate 
(50 M) and H2O2 (300 M) but also on untreated cells (Figure 6). As expected, the increase in ROS 
production was particularly noticeable in samples exposed to oxidative conditions, with the strong 
overexpression sample (100-tet-HEK-cFXN) showing the highest response. The mild overexpression 
sample (10-tet-HEK-cFXN) was also clearly affected by the presence of the oxidising agent although 
at a lower intensity than the 8-day-HEK-cFXN control. An increase in MitoSOX Red fluorescence, 
albeit at a decisively lower intensity, was also detected in untreated 100-tet-HEK-cFXN. No 
significant difference from the control was evident for the mild overexpression samples (10-tet-HEK-
cFXN). 
 
Discussion 
We have shown here how the nanomotion sensor can be adapted and optimised to follow the 
metabolic landscape of cells designed to mimic a specific disease or explore the effects of genetic 
modifications. FRDA, a genetic disease linked to iron accumulation and metabolic variations, was 
chosen as a particularly suitable case study in view of the several debates on the role of oxidative 
stress as a primary cause or a secondary effect of the FRDA pathology [1, 17]. We had previously 
studied the effects of frataxin overexpression because this is a possible strategy that could be used to 
cure the disease. Lack of frataxin is lethal, as shown by early studies that have demonstrated that mice 
knockout models die at the embryonal level [24]. Accordingly, the disease starts appearing when the 
frataxin levels are below 30% those of healthy controls and are 10-35% the normal levels in FRDA 
patients [15]. On the other hand, it was found that frataxin overexpression is not a solution as a 
therapeutic strategy: overexpression seems to be as toxic as its partial depletion [20, 25, 26]. This 
observation is perfectly coherent with the current hypothesis that frataxin functions as a regulator of 
the process of conversion of cysteine into alanine through interaction with the desulfurase central to 
the machine of the iron sulfur cluster biogenesis machine [27]. 
Our interest here was to explore if the nanosensor could give us more details on the basis of 
the observed toxicity of overexpression and precise hints on when the effects start to be observable. 
We first optimised the technique for our specific type of cells. The setup we implemented is 
inexpensive, small and easy to handle. It will thus be amenable to a wider and more standardised use 
in the future. Some aspects may be improved: in our current setup, the time span covered in the 
experiments is limited by the evaporation of the medium in the measuring chamber. Currently the 
plate contains small volumes (1 ml) which are needed to optimise the diffusion rate of peroxide. The 
problem can, in the future, be reduced or solved by the use of a perfusion chamber similar to those 
that have been employed in previous studies [28]. 
We observed that frataxin overexpression has profound metabolic effects that are not linear. 
Our data clearly showed that increased levels of frataxin overexpression negatively affect the ability 
of the cell to respond to oxidative stress, also in the absence of iron overload. All cells evidenced a 
response to H2O2 as it could be expected. However, the 8-day-HEK-cFXN control recovered rapidly 
and had relatively small perturbations, while the other cells showed a more complex and stronger 
response. Both mild and strong frataxin-overexpression samples displayed a series of minima in 
response to the stress in general more intense than those of the control. The 100-tet-HEK-cFXN cells 
treated both with ferric ammonium citrate and peroxide were the only case in which, at the end of the 
monitoring period, the basal movement did not recover and was still responding with a third 
minimum. This observation suggested that these cells need more time to recover and have a stronger 
sensibility to oxidative stress. It is interesting to highlight how the oscillation amplitude of the 
nanomotion signal of the 100-tet-HEK-cFXN cells also increased above basal levels.      . 
In the whole, the nanomotion results are fully consistent with what we could observe by more 
conventional techniques as proven here by MitoSOX experiments and as previously shown by other 
techniques [20]. These more traditional approaches are nevertheless unable to monitor when the 
complex metabolic response of the cell take place. Conversely, the nanosensor measurements do not 
tell us which metabolic reactions occur but provide a direct profile of when the changes occur and 
add a time-resolved perspective on the cellular response to environmental insults. The nanosensor 
results tell us, for instance, that the effects of ROS on the metabolism protract for longer than the 30 
min windows explored in the MitoSOX red measurements, an information that could not be extracted 
otherwise. The nanosensor measurements thus provide direct information on the metabolic landscape 
of the cellular response. In the future, it will be appropriate to couple nanomotion experiments with 
traditional approaches such as fluorescent markers to obtain first a more complete picture of what 
happens to the cell in real time and then explore with other means what is happening at the time points 
indicated by the nanosensor. This new possibility will open a new way to test the effects of drugs on 
cell models of FRDA and evaluate the effects produced by induced oxidative stress on the cellular 
metabolic activity. It is not farfetched to predict that the nanomotion sensor may be applied more in 
general to the study of neurodegenerative diseases, such as Parkinson and Alzheimer diseases, and 
be in a not too far future exploited as a powerful tool to explore the response to drugs of patients’ cell 
cultures in personalized medicine. 
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Figure legends 
Figure 1 – Depiction of the immobilization protocol of the HEK cells on the nanosensor. The sensor 
is monitored by optical microscopy to approach a cell. The chemically-activated surface of the sensor 
is pressed over the cell for 1 minute in order to ensure attachment and then retracted to extract the 
cell. This procedure is repeated in order to obtain 3-5 cells over a single sensor to perform the 
nanomotion experiment. 
                                    
Figure 2 – Control experiments for the establishment of the method. Measurements on (A) 10-tet-
HEK-cFXN and (B) 100-tet-HEK-cFXN cells in a medium containing ferric ammonium citrate 
recorded over 50 minutes time. The response was normalized to the average value calculated on the 
fluctuations in culture medium without addition of peroxide.  
 
Figure 3 – Effects of hydrogen peroxide on HEK-cFXN cells. Nanomotion experiments of the (A) 8-
day-HEK-cFXN; (B) 10-tet-HEK-cFXN; (C) 100-tet-HEK-cFXN cells exposed to oxidative stress. 
The cells were cultured overnight in the presence of ferric ammonium citrate (50 M) and then 
exposed to H2O2 to a final concentration of 300 M after a stabilizing period of 1 h in growth medium. 
 
Figure 4 – Effects of hydrogen peroxide on the cell morphology. Optical images of the 8-day-HEK-
cFXN (top panels), 10-tet-HEK-cFXN (middle panels) and 100-tet-HEK-cFXN (lower panels), before 
(left), 5 minutes (center) and 40 minutes (right) after exposure to peroxide. The images show that 
there is no evident morphological modifications of the cells. 
 
Figure 5 – Effects of hydrogen peroxide in the absence of ferric ammonium citrate. Nanomotion 
experiments of (A) 10-tet-HEK-cFXN and (B) 100-tet-HEK-cFXN cells exposed to oxidative stress. 
The response was normalized to the average value calculated on the fluctuations of the corresponding 
medium. (C) Optical images of 10-tet-HEK-cFXN (top panels) and 100-tet-HEK-cFXN (lower 
panels), before (left), 5 minutes (center) and 40 minutes (right) after exposure to H2O2. 
 
Figure 6 – Measurements of oxidative stress by flow cytometry. The experiments were carried out 
using 1.25 M MitoSOX Red on both untreated cells (-H2O2) and on cells under acute oxidative 
condition (+H2O2). Frataxin overexpression has a clear negative effect on the response of the cells to 
oxidative stress conditions. This effect, although at a lower level, can be seen even when cells are not 
treated with H2O2. Data expressed as means ± SD (n =3/5). **, P≤0.0045 and ****, P ≤0.0001 
compared to 8-day control sample. 
